Search

Anti-Müllerian hormone (AMH) has been reported to be elevated in mares with granulosa cell tumour (GCT). An 8-year-old Thoroughbred mare was presented for not being observed in oestrus after the beginning of the breeding season. Rectal palpation and ultrasonography revealed enlargement and cystic appearance of the left ovary while the right ovary was small with an anoestrous-like appearance. The AMH concentration was 694.9 ng/ml. Presumptively diagnosed with GCT, the mare was subjected to tumour removal. Histopathology confirmed GCT. To evaluate changes of AMH concentration following surgery, blood samples were collected immediately prior to surgery, and on Days 1, 2, 4, 8, 16 and 32 after surgery. Thereafter, blood samples were collected monthly and also at the time the mare was observed in oestrus (148 days after tumour removal). The AMH concentrations decreased over the first 2 months after surgery (from 721.2 ng/ml to 0.1 ng/ml). Subsequently, AMH concentration increased and peaked at the time of oestrus expression (0.7 ng/ml). The mare then became anoestrous, and AMH concentration decreased and reached 0.2 ng/ml, which was not significantly different from the mean concentration of AMH in normal anoestrous mares (n = 5; 0.26 ± 0.07 ng/ml). In conclusion, the present report implies the potential use of AMH for determination of the time of follicular resumption in mares after GCT removal. [ABSTRACT FROM AUTHOR]

The article reports on the study of Anti-Müllerian hormone (AMH) and its potential role as a biomarker for differential diagnosis of dogs with cryptorchidism. It mentions the disease's predisposition of the animal to the neoplasia of its testicles leading to its surgical removal. It also notes the production of the hormone through Settoli cells in various mammalian species as well as significance in sexual differentiation.